Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc. (CERE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CERE · as of Sep 30, 2024
Ownership Breakdown
2
Institutional Holders
▼ 270 vs Q2
$20,686
Total Inst. Value
▼ $6.42B vs Q2
182.20M
Shares Outstanding
freeFloat 42.71%
472
13F Shares Held
▼ 156.97M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CERE largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
IFP ADVISORS, INC pharmaceutical preparations | 346 | 0.02% | 0.02% | $15.53M | Feb 4, 2025 | ▼ 418 |
RONALD BLUE TRUST, INC. pharmaceutical preparations | 126 | 0.01% | 0.01% | $5.15M | Oct 17, 2024 | ▲ 7 |
COWEN AND COMPANY, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 12, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2024 | EXIT |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2024 | EXIT |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
STATE STREET CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
ROTHSCHILD INVESTMENT LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Oct 18, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2024 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
1
Increased
+7 shares0
New Positions
first time holders1
Decreased
−418 shares48
Sold Out
fully exitedNet shares change (top 50)
411
+7 / −418
Net new holders
-48
0 new / 48 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CERE insider trading · insider activity
Source: SEC Form 4
1
Buy transactions
2
Sell transactions
0.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
PFIZER INC Former 10% Owner | Aug 1, 2024 | U-Tender | 27,349,211 | $45.00 | $1.23B | 0 | Form 4 ↗ |
BAIN CAPITAL INVESTORS LLC
| Aug 1, 2024 | D-Return | 65,679,781 | $45.00 | $2.96B | 0 | Form 4 ↗ |
Gordon Christopher R
| Aug 1, 2024 | D-Return | 3,282 | $45.00 | $147.7K | 10.5K | Form 4 ↗ |
Gordon Christopher R
| Aug 1, 2024 | D-Return | 80,189 | — | — | 0 | Form 4 ↗ |
Gordon Christopher R
| Aug 1, 2024 | D-Return | 65,679,781 | $45.00 | $2.96B | 0 | Form 4 ↗ |
Gordon Christopher R
| Aug 1, 2024 | D-Return | 10,461 | — | — | 0 | Form 4 ↗ |
Koppel Adam
| Aug 1, 2024 | D-Return | 3,282 | $45.00 | $147.7K | 10.5K | Form 4 ↗ |
Koppel Adam
| Aug 1, 2024 | D-Return | 65,679,781 | $45.00 | $2.96B | 0 | Form 4 ↗ |
Koppel Adam
| Aug 1, 2024 | D-Return | 10,461 | — | — | 0 | Form 4 ↗ |
Koppel Adam
| Aug 1, 2024 | D-Return | 80,189 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cerevel Therapeutics Holdings, Inc. (CERE) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 57.29%, while retail and public investors account for the remaining 42.71%.
The largest institutional shareholder of Cerevel Therapeutics Holdings, Inc. is IFP ADVISORS, INC, holding approximately 346 shares — equal to 0.02% of outstanding shares — as of September 30, 2024.
A total of 2 institutional investors currently hold CERE stock, with a combined institutional value of approximately $20,686 as of the most recent 13F filing period.
Frequently asked questions
CERE ownershipCerevel Therapeutics Holdings, Inc. (CERE) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is IFP ADVISORS, INC with a 0.02% stake. Company insiders hold 57.29%. Data sourced from SEC Form 13F as of September 30, 2024.